SCENESSE 16 mg implant

Licence status
Authorised: 22/12/2014
Active substances
Afamelanotide
Dosage Form
Implant
Licence number
EU/1/14/969/001
Licence holder
Clinuvel Europe Limited

Product documents

Licence information

ATC code
D02BB Protectives against UV-radiation for systemic use, D02BB02 afamelanotide
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/12/2014